Genitourinary Disease & Epidemiology Overview, 2018-2028 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 18, 2018--The “Genitourinary - Disease & Epidemiology Overview” report from Decision Resources Group has been added to ResearchAndMarkets.com’s offering.
The global epidemiology overviews provide insights including global diagnosed prevalence, diagnosed prevalence by region, 10-year diagnosed prevalence growth forecast, relative sizes of the factors contributing to the trend in prevalent cases, and more, for each indication.
The Genitourinary Disease & Epidemiology Overview report provides disease market overviews and global epidemiology overviews for 5 indications in the Genitourinary therapy area:
Overactive Bladder,Male Hypogonadism,Endometriosis,Female Infertility and Uterine Fibroids Disease. This report provides a disease market overview for each indication and global epidemiology overviews for each indication.
The disease market overviews include information such as market size forecasts, prevailing treatment trend analysis and predictions, key areas of unmet need, current and emerging therapies, physician (KOL) insights, clinical pipeline analysis, and more, for each indication.
Key Topics Covered:About the Analyst About the analyst’s Epidemiology Disease Landscape and Insight Overview Epidemiology Overview
Companies MentionedAbbvie Myovant ObsEva’s Astellas Ogeda Bayer Evotec’s
For more information about this report visit https://www.researchandmarkets.com/research/nbzx5b/genitourinary?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181218005303/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Urological Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/18/2018 04:07 AM/DISC: 12/18/2018 04:07 AM